Forward-Looking Statements



This Quarterly Report on Form 10-Q may include certain forward-looking
statements based on current management expectations. Such forward-looking
statements may be identified by reference to a future period or periods or by
the use of forward-looking terminology, such as "may", "will", "believe",
"expect", "estimate", "anticipate", "continue", or similar terms or variations
on those terms, or the negative of those terms. The actual results of the
Company could differ materially from those management expectations. This
includes statements regarding general economic conditions, public health crisis
such as the governmental, social and economic effects of the novel coronavirus,
legislative and regulatory changes, monetary and fiscal policies of the federal
government, changes in tax policies, rates and regulations of federal, state and
local tax authorities and failure to integrate or profitably operate acquired
businesses. Additional potential factors include changes in interest rates, the
rate of inflation, deposit flows, cost of funds, demand for loan products and
financial services, competition and changes in the quality or composition of
loan and investment portfolios of the Company. Other factors that could cause
future results to vary from current management expectations include changes in
accounting principles, policies or guidelines, and other economic, competitive,
governmental and technological factors affecting the Company's operations,
markets, products, services and prices. Further description of the risks and
uncertainties to the business are included in the Company's other filings with
the Securities and Exchange Commission.

In addition, the COVID-19 pandemic has had, and may continue to have, an adverse
impact on the Company, its clients and the communities it serves. Given its
dynamic nature, it is difficult to predict the full impact of the COVID-19
pandemic on our business. Reference is made to Item 1A "Risk Factors" in the
Company's Annual Report on Form 10-K for the year ended June 30, 2022.

Except as required by applicable law or regulation, the Company does not
undertake, and specifically disclaims any obligation, to release publicly the
result of any revisions that may be made to any forward-looking statements to
reflect events or circumstances after the date of the statements or to reflect
the occurrence of anticipated or unanticipated events.

Critical Accounting Policies



Our accounting policies are integral to understanding the results reported. We
consider accounting policies that require management to exercise significant
judgment or discretion or to make significant assumptions that have, or could
have, a material impact on the carrying value of certain assets or on income to
be critical accounting policies. At September 30, 2022, there have been no
material changes to our critical accounting policies as compared to the critical
accounting policies disclosed in our most recent Annual Report on Form 10-K.
Reference is made to Item 7 "Management's Discussion and Analysis of Financial
Condition and Results of Operations" in the Company's Annual Report on Form 10-K
for the year ended June 30, 2022.

Comparison of Financial Condition at September 30, 2022 and June 30, 2022



Executive Summary. Total assets increased $169.7 million to $7.89 billion at
September 30, 2022 from $7.72 billion at June 30, 2022. The increase primarily
reflected an increase in net loans receivable, partially offset by a decrease in
investment securities.

Investment Securities. Investment securities available for sale decreased $80.9
million to $1.26 billion at September 30, 2022, from $1.34 billion at June 30,
2022. This decrease was largely the result of a fair value decrease of $49.4
million and principal repayments of $31.3 million.

Investment securities held to maturity decreased $2.3 million to $115.9 million
at September 30, 2022 from $118.3 million at June 30, 2022. This decrease was
the result of principal repayments of $2.3 million.

Additional information regarding our investment securities at September 30, 2022
and June 30, 2022 is presented in Note 4 to the unaudited consolidated financial
statements.

Loans Held-for-Sale. Loans held-for-sale totaled $12.9 million at September 30,
2022 as compared to $28.9 million at June 30, 2022 and are reported separately
from the balance of net loans receivable. During the three months ended
September 30, 2022, we sold $42.5 million of residential mortgage loans,
resulting in a gain on sale of $312,000, and $14.3 million of commercial
mortgage loans, resulting in a net gain on sale of $28,000.
                                     - 36 -

--------------------------------------------------------------------------------

Index



Net Loans Receivable. Net loans receivable increased $238.0 million, or 4.4%, to
$5.61 billion at September 30, 2022 from $5.37 billion at June 30, 2022. Details
regarding the change in the loan portfolio, by loan segment, is presented below:

                                             September 30,        June 30,        Increase/
                                                  2022              2022          (Decrease)
                                                             (In Thousands)
Commercial loans:
Multi-family mortgage                       $    2,570,297      $ 2,409,090      $  161,207
Nonresidential mortgage                          1,040,688        1,019,838          20,850
Commercial business                                186,361          176,807           9,554
Construction                                       166,052          140,131          25,921
Total commercial loans                           3,963,398        3,745,866         217,532

One- to four-family residential mortgage 1,666,730 1,645,816


         20,914

Consumer loans:
Home equity loans                                   43,269           42,028           1,241
Other consumer                                       2,869            2,866               3
Total consumer loans                                46,138           44,894           1,244

Total loans                                      5,676,266        5,436,576         239,690

Unaccreted yield adjustments                       (19,896)         (18,731)         (1,165)
Allowance for credit losses                        (47,613)         (47,058)           (555)

Net loans receivable                        $    5,608,757      $ 5,370,787      $  237,970


Commercial loan origination volume for the three months ended September 30, 2022
totaled $341.1 million, comprised of $282.9 million of commercial mortgage loan
originations, $31.9 million of commercial business loan originations and
construction loan disbursements of $26.3 million.

One- to four-family residential mortgage loan origination volume, excluding loans held-for-sale, totaled $63.8 million for the three months ended September 30, 2022 and was supplemented with the purchase of loans totaling $656,000. Home equity loan and line of credit origination volume for the same period totaled $6.9 million.



Loan-to-value ("LTV") ratios are based on current period loan balances and
original appraised values at the time of origination unless a current appraisal
has been obtained as a result of the loan being deemed collateral dependent and
individually analyzed. The following table sets forth the composition of our
real estate secured loans indicating the LTV, by loan category, at September 30,
2022 and June 30, 2022:

                                                  September 30, 2022               June 30, 2022
                                                   Balance           LTV         Balance         LTV
                                                              (Dollars in Thousands)
Commercial mortgage loans:
Multi-family mortgage                        $       2,570,297       64  %    $  2,409,090       64  %
Nonresidential mortgage                              1,040,688       54          1,019,838       54
Construction                                           166,052       61            140,131       61
Total commercial mortgage loans                      3,777,037       61     

3,569,059 61



One- to four-family residential mortgage             1,666,730       62          1,645,816       62

Consumer loans:
Home equity loans                                       43,269       47             42,028       46

Total mortgage loans                         $       5,487,036       61  %    $  5,256,903       61  %


                                     - 37 -

--------------------------------------------------------------------------------

Index

Additional information about our loans at September 30, 2022 and June 30, 2022 is presented in Note 5 to the unaudited consolidated financial statements.



Nonperforming Assets and TDRs. Nonperforming assets decreased by $14.8 million
to $77.4 million, or 0.98% of total assets, at September 30, 2022, from $92.2
million, or 1.19% of total assets, at June 30, 2022. At September 30, 2022, we
had accruing TDRs totaling $8.9 million, an increase of $273,000 from $8.7
million at June 30, 2022. At September 30, 2022, we had non-accrual TDRs
totaling $11.8 million, a decrease of $1.7 million from $13.5 million at
June 30, 2022.

At September 30, 2022, nonperforming assets consisted of $68.6 million of
nonperforming loans, $8.7 million of non-accrual commercial loans held for sale
and $178,000 of other real estate owned. At June 30, 2022, nonperforming assets
consisted of $70.3 million of nonperforming loans, $21.7 million of non-accrual
commercial loans held for sale and $178,000 of other real estate owned.

Additional information about our nonperforming loans and TDRs at September 30, 2022 and June 30, 2022 is presented in Note 5 to the unaudited consolidated financial statements.



Allowance for Credit Losses ("ACL"). At September 30, 2022, the ACL totaled
$47.6 million, or 0.84% of total loans, reflecting an increase of $555,000 from
$47.1 million, or 0.87% of total loans, at June 30, 2022. The increase during
the three months ended September 30, 2022 was largely attributable to a
provision for credit losses of $670,000, primarily driven by loan growth in the
quarter, partially offset by a reduction in the expected life of the loan
portfolio.

Additional information about our ACL at September 30, 2022 and June 30, 2022 is presented in Note 6 to the unaudited consolidated financial statements.



Other Assets. The aggregate balance of other assets, including premises and
equipment, FHLB stock, interest receivable, goodwill, core deposit intangibles,
bank owned life insurance, deferred income taxes, OREO and other assets,
increased $36.5 million to $792.7 million at September 30, 2022 from $756.2
million at June 30, 2022. The increase in the balance of these other assets
during the three months ended September 30, 2022 largely reflected a $25.3
million increase in the fair value of our derivatives portfolio. The remaining
change generally reflected normal operating fluctuations within these line
items.

Deposits. Total deposits increased $246.0 million, or 4.2%, to $6.11 billion at
September 30, 2022 from $5.86 billion at June 30, 2022. The following table sets
forth the distribution of, and changes in, deposits, by type, for the periods
indicated:

                                  September 30,        June 30,        Increase/
                                       2022              2022          (Decrease)
                                                  (In Thousands)
Non-interest-bearing deposits    $      683,406      $   653,899      $   29,507

Interest-bearing deposits:
Interest-bearing demand               2,382,411        2,265,597         116,814
Savings                                 982,916        1,053,198         (70,282)
Certificates of deposit               2,059,545        1,889,562         169,983
Interest-bearing deposits             5,424,872        5,208,357         216,515
Total deposits                   $    6,108,278      $ 5,862,256      $  246,022

Additional information about our deposits at September 30, 2022 and June 30, 2022 is presented in Note 7 to the unaudited consolidated financial statements.

Borrowings. The balance of borrowings decreased by $49.9 million to $851.5 million at September 30, 2022 from $901.3 million at June 30, 2022.

Additional information about our borrowings at September 30, 2022 and June 30, 2022 is presented in Note 8 to the unaudited consolidated financial statements.



Other Liabilities. The balance of other liabilities, including advance payments
by borrowers for taxes and other miscellaneous liabilities, decreased $7.4
million to $54.9 million at September 30, 2022 from $62.3 million at June 30,
2022. The change in the balance of these other liabilities generally reflected
normal operating fluctuations during the period.
                                     - 38 -

--------------------------------------------------------------------------------

Index



Stockholders' Equity. Stockholders' equity decreased $19.0 million to $875.0
million at September 30, 2022 from $894.0 million at June 30, 2022. The decrease
in stockholders' equity during the three months ended September 30, 2022 largely
reflected other comprehensive loss, net of income tax, of $20.6 million, which
was driven by a decline in the fair value of our available for sale securities,
partially offset by an increase in the fair value of our derivatives portfolio.
In addition, share repurchases totaled $8.7 million and cash dividends totaled
$7.3 million. These items were partially offset by net income of $16.5 million.

Book value per share decreased by $0.14 to $12.88 at September 30, 2022 while tangible book value per share decreased by $0.17 to $9.73 at September 30, 2022.



On August 1, 2022, we announced the authorization of a new stock repurchase
plan, which authorized the repurchase of up to 4,000,000 shares, and the
completion of our previous stock repurchase plan, which authorized the
repurchase of 7,602,021 shares. During the quarter ended September 30, 2022, we
repurchased 759,806 shares of common stock at a cost of $8.7 million, or $11.44
per share. Through September 30, 2022, we repurchased a total of 434,661 shares,
or 10.9% of the shares authorized for repurchase under the current repurchase
program, at a total cost of $5.1 million or $11.66 per share.

Comparison of Operating Results for the Quarter Ended September 30, 2022 and September 30, 2021



Net Income. Net income for the quarter ended September 30, 2022 was $16.5
million, or $0.25 per diluted share, compared to $19.7 million, or $0.26 per
diluted share for the quarter ended September 30, 2021. The decrease in net
income reflected a decrease in net interest income, an increase in the provision
for credit losses and an increase in non-interest expense, partially offset by
an increase in non-interest income and a decrease in income tax expense.

Net Interest Income. Net interest income decreased by $1.1 million to $48.5
million for the quarter ended September 30, 2022 compared to $49.6 million for
the quarter ended September 30, 2021. The decrease between the comparative
periods resulted from an increase of $8.3 million in interest expense, partially
offset by an increase of $7.2 million in interest income. Included in net
interest income for the quarters ended September 30, 2022 and 2021,
respectively, was purchase accounting accretion of $1.8 million and $2.9
million, and loan prepayment penalty income of $441,000 and $1.7 million.

Net interest margin decreased 30 basis points to 2.69% for the quarter ended
September 30, 2022, from 2.99% for the quarter ended September 30, 2021 and
reflected an increase in the cost of interest-bearing liabilities, partially
offset by increases in the average balance and yield on interest-earning assets.
                                     - 39 -

--------------------------------------------------------------------------------

Index



Details surrounding the composition of, and changes to, net interest income are
presented in the table below which reflects the components of the average
balance sheet and of net interest income for the periods indicated. We derived
the average yields and costs by dividing income or expense by the average
balance of assets or liabilities, respectively, for the periods presented with
daily balances used to derive average balances. No tax equivalent adjustments
have been made to yield or costs. Non-accrual loans were included in the
calculation of average balances, however interest receivable on these loans has
been fully reserved for and therefore not included in interest income. The
yields and costs set forth below include the effect of deferred fees, discounts
and premiums that are amortized or accreted to interest income or expense.

                                                                              Three Months Ended September 30,
                                                              2022                                                         2021
                                                                                Average                                                      Average
                                        Average                                 Yield/               Average                                 Yield/
                                        Balance            Interest              Cost                Balance            Interest              Cost
                                                                                   (Dollars in Thousands)
Interest-earning assets:
Loans receivable (1)                 $ 5,553,996          $ 52,935                  3.81  %       $ 4,835,676          $ 48,230                  3.99  %
Taxable investment securities (2)      1,516,974            10,439                  2.75            1,649,953             8,212                  1.99
Tax-exempt securities (2)                 48,973               285                  2.33               59,115               333                  2.25
Other interest-earning assets (3)         88,038               761                  3.46               85,749               431                  2.01
Total interest-earning assets          7,207,981            64,420                  3.57            6,630,493            57,206                  3.45
Non-interest-earning assets              570,225                                                      616,735
Total assets                         $ 7,778,206                                                  $ 7,247,228

Interest-bearing liabilities:
Interest-bearing demand              $ 2,354,340             5,391                  0.92          $ 1,954,271             1,147                  0.23
Savings                                1,019,343               595                  0.23            1,102,865               334                  0.12
Certificates of deposit                2,014,922             4,883                  0.97            1,798,473             2,584                  0.57
Total interest-bearing deposits        5,388,605            10,869                  0.81            4,855,609             4,065                  0.33
Federal Home Loan Bank advances          642,399             4,301                  2.68              665,915             3,544                  2.13
Other borrowings                         127,456               719                  2.26               28,532                 7                  0.10
Borrowings                               769,855             5,020                  2.61              694,447             3,551                  2.05
Total interest-bearing liabilities     6,158,460            15,889                  1.03            5,550,056             7,616                  0.55
Non-interest-bearing liabilities (4)     724,055                                                      667,164
Total liabilities                      6,882,515                                                    6,217,220
Stockholders' equity                     895,691                                                    1,030,008
Total liabilities and stockholders'
equity                               $ 7,778,206                                                  $ 7,247,228

Net interest income                                       $ 48,531                                                     $ 49,590
Interest rate spread (5)                                                            2.54  %                                                      2.90  %
Net interest margin (6)                                                             2.69  %                                                      2.99  %
Ratio of interest-earning assets to
interest-bearing liabilities                   1.17                                                         1.19


___________________________________


(1)Loans held-for-sale and non-accruing loans have been included in loans
receivable and the effect of such inclusion was not material. Allowance for
credit losses has been included in non-interest-earning assets.
(2)Fair value adjustments have been excluded in the balances of interest-earning
assets.
(3)Includes interest-bearing deposits at other banks and FHLB of New York
capital stock.
(4)Includes average balances of non-interest-bearing deposits of $667.6 million
and $610.3 million for the quarter ended September 30, 2022 and 2021,
respectively.
(5)Interest rate spread represents the difference between the yield on
interest-earning assets and the cost of interest-bearing liabilities.
(6)Net interest margin represents net interest income as a percentage of average
interest-earning assets.
                                     - 40 -

--------------------------------------------------------------------------------

Index



Provision for Credit Losses. The provision for credit losses increased $6.1
million to a provision for credit losses of $670,000 for the quarter ended
September 30, 2022, compared to a provision for credit losses reversal of $5.4
million for the quarter ended September 30, 2021. The provision for the quarter
ended September 30, 2022 was largely attributable to loan growth in the quarter,
partially offset by a reduction in the expected life of the loan portfolio. By
comparison, the provision reversal for the quarter ended September 30, 2021 was
largely attributable to a reduction in the expected life of various loan
segments and continued improvement in our credit risk outlook.

Additional information regarding the ACL and the associated provisions recognized during the quarters ended September 30, 2022 and 2021 is presented in Note 6 to the unaudited consolidated financial statements as well as the Comparison of Financial Condition at September 30, 2022 and June 30, 2022.

Non-Interest Income. Total non-interest income increased $2.1 million to $5.9 million for the quarter ended September 30, 2022.



Gain on sale of loans decreased $611,000 to $395,000 for the quarter ended
September 30, 2022. The decrease in loan sale gains largely reflected a lower
average sales price of loans sold and a decrease in the volume of loans sold
between comparative periods largely attributable to increases in market interest
rates.

Income from bank owned life insurance increased $2.1 million to $3.7 million for
the quarter ended September 30, 2022. The increase is the result of payouts on
life insurance policies.

Other non-interest income increased $337,000 to $555,000 for the quarter ended September 30, 2022. The increase in other non-interest income primarily reflected income from investment services.



The remaining changes in the other components of non-interest income between
comparative periods generally reflected normal operating fluctuations within
those line items.

Non-Interest Expense. Total non-interest expense increased $185,000 to $32.0 million for the quarter ended September 30, 2022.



Salaries and employee benefits increased $1.7 million to $20.3 million for
quarter ended September 30, 2022. This increase was largely due to the impact of
staff additions, annual merit increases and an increase in incentive payments
tied to loan origination volume. Partially offsetting these increases was a
decrease in stock-based compensation expense.

Net occupancy expense of premises decreased $1.5 million to $3.1 million for the
quarter ended September 30, 2022. This decrease was primarily due to $1.3
million of non-recurring expenses related to the consolidation of three retail
branch locations recognized in the prior period.

The remaining changes in the other components of non-interest expense between
comparative periods generally reflected normal operating fluctuations within
those line items.

Provision for Income Taxes. Provision for income taxes decreased $2.0 million to
$5.3 million for the quarter ended September 30, 2022 from $7.3 million for the
quarter ended September 30, 2021.

The decrease in income tax expense reflected a lower level of pre-tax income as compared to the prior period.



Effective tax rates for the quarter ended September 30, 2022 and 2021 were 24.1%
and 26.9%, respectively. The decrease in the effective tax rate primarily
resulted from the payouts on life insurance policies, noted above, which were
not taxable.


                                     - 41 -

--------------------------------------------------------------------------------

Index

Liquidity and Capital Resources



Liquidity, represented by cash and cash equivalents, is a product of operating,
investing and financing activities. Our primary sources of funds are deposits,
borrowings, cash flows from investment securities and loans receivable and funds
provided from operations. While scheduled payments from the amortization and
maturity of loans and investment securities are relatively predictable sources
of funds, general interest rates, economic conditions and competition greatly
influence deposit flows and prepayments on loans and securities.

At September 30, 2022, liquidity included $96.1 million of short-term cash and
equivalents and $1.26 billion of investment securities available for sale. In
addition, as of September 30, 2022, we had the capacity to borrow additional
funds totaling $2.26 billion and $284.0 million from the FHLB of New York and
FRB, respectively, without pledging additional collateral. As of that same date,
we also had access to unsecured overnight borrowings with other financial
institutions totaling $970.0 million of which none was outstanding.

At September 30, 2022, we had outstanding commitments to originate and purchase
loans totaling $352.2 million while such commitments totaled $242.1 million at
June 30, 2022. As of those same dates, our pipeline of loans held for sale
included $12.8 million and $20.3 million, respectively, of loans in process
whose terms included interest rate locks to borrowers that were paired with a
best-efforts commitment to sell the loan to a buyer at a fixed price and within
a predetermined timeframe after the sale commitment is established.

Construction loans in process and unused lines of credit were $80.2 million and
$159.7 million, respectively, at September 30, 2022 compared to $109.0 million
and $159.3 million, respectively, at June 30, 2022. We are also subject to the
contingent liabilities resulting from letters of credit whose outstanding
balances totaled $115,000 and $130,000, at September 30, 2022 and June 30, 2022,
respectively.

Commitments to extend credit are agreements to lend to a customer as long as
there is no violation of any condition established in the contract. Commitments
generally have fixed expiration dates or other termination clauses and may
require payment of a fee by the customer. Our exposure to credit loss in the
event of nonperformance by the other party to the financial instrument for
commitments to extend credit is represented by the contractual notional amount
of those instruments. We use the same credit policies in making commitments and
conditional obligations as we do for on-balance-sheet instruments. Since many of
the commitments are expected to expire without being drawn upon, the total
commitment amounts do not necessarily represent future cash requirements.

Consistent with its goals to operate a sound and profitable financial organization, the Bank actively seeks to maintain its status as a well-capitalized institution in accordance with regulatory standards.



The following table sets forth the Bank's capital position at September 30, 2022
and June 30, 2022, as compared to the minimum regulatory capital requirements
that were in effect as of those dates:

                                                                                      At September 30, 2022
                                                                                                                             To Be Well Capitalized
                                                                                                                                  Under Prompt
                                                                                          For Capital                           Corrective Action
                                                    Actual                             Adequacy Purposes                           Provisions
                                          Amount              Ratio               Amount               Ratio               Amount               Ratio
                                                                                     (Dollars in Thousands)
Total capital (to risk-weighted
assets)                                $ 683,381                12.67  %       $  431,361                8.00  %       $   539,202                10.00 

%


Tier 1 capital (to risk-weighted
assets)                                  648,894                12.03  %          323,521                6.00  %           431,361                 8.00

%


Common equity tier 1 capital (to
risk-weighted assets)                    648,894                12.03  %          242,641                4.50  %           350,481                 6.50

%


Tier 1 capital (to adjusted total
assets)                                  648,894                 8.44  %          307,371                4.00  %           384,214                 5.00  %


                                     - 42 -

--------------------------------------------------------------------------------


  Index

                                                                                        At June 30, 2022
                                                                                                                             To Be Well Capitalized
                                                                                                                                  Under Prompt
                                                                                          For Capital                           Corrective Action
                                                    Actual                             Adequacy Purposes                           Provisions
                                          Amount              Ratio               Amount               Ratio               Amount               Ratio
                                                                                     (Dollars in Thousands)
Total capital (to risk-weighted
assets)                                $ 672,274                13.10  %       $  410,429                8.00  %       $   513,036                10.00 

%


Tier 1 capital (to risk-weighted
assets)                                  642,336                12.52  %          307,822                6.00  %           410,429                 8.00

%


Common equity tier 1 capital (to
risk-weighted assets)                    642,336                12.52  %          230,866                4.50  %           333,473                 6.50

%


Tier 1 capital (to adjusted total
assets)                                  642,336                 8.70  %          295,163                4.00  %           368,954                 5.00  %

The following table sets forth the Company's capital position at September 30, 2022 and June 30, 2022, as compared to the minimum regulatory capital requirements that were in effect as of those dates:



                                                                         At September 30, 2022
                                                                                                    For Capital
                                                           Actual                                Adequacy Purposes
                                               Amount                 Ratio                Amount                Ratio
                                                                         (Dollars in Thousands)
Total capital (to risk-weighted assets)     $  781,745                   14.49  %       $  431,480                   8.00  %
Tier 1 capital (to risk-weighted assets)       747,258                   13.85  %          323,610                   6.00  %
Common equity tier 1 capital (to
risk-weighted assets)                          747,258                   13.85  %          242,707                   4.50  %
Tier 1 capital (to adjusted total assets)      747,258                    9.72  %          307,523                   4.00  %


                                                                           At June 30, 2022
                                                                                                   For Capital
                                                           Actual                               Adequacy Purposes
                                               Amount                Ratio                Amount                Ratio
                                                                        (Dollars in Thousands)
Total capital (to risk-weighted assets)     $ 778,253                   15.17  %       $  410,515                   8.00  %
Tier 1 capital (to risk-weighted assets)      748,315                   14.58  %          307,886                   6.00  %
Common equity tier 1 capital (to
risk-weighted assets)                         748,315                   14.58  %          230,914                   4.50  %
Tier 1 capital (to adjusted total assets)     748,315                   10.14  %          295,290                   4.00  %


In March 2020, the federal banking agencies announced an interim final rule to
delay the estimated impact on regulatory capital stemming from the
implementation of CECL. The interim final rule provides banks the option to
delay for two years an estimate of CECL's effect on regulatory capital, relative
to the incurred loss method, followed by a three-year transition period
established in the previous rule (five-year transition option). We have adopted
the capital transition relief over the permissible five-year period. The
two-year delay ended for us as of June 30, 2022 and we then began the three-year
transition period.

Off-Balance Sheet Arrangements



In the normal course of our business of investing in loans and securities we are
a party to financial instruments with off-balance-sheet risk. These financial
instruments include significant purchase commitments, such as commitments
related to capital expenditure plans and commitments to extend credit to meet
the financing needs of our customers. We had no significant off-balance sheet
commitments for capital expenditures as of September 30, 2022.

Recent Accounting Pronouncements

For a discussion of the expected impact of recently issued accounting pronouncements that we have yet to adopt, please refer to Note 3 to the unaudited consolidated financial statements.


                                     - 43 -

--------------------------------------------------------------------------------

Index


                                    ITEM 3.

© Edgar Online, source Glimpses